Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer

JAMA

Volumn 307, Issue 17, 2012, Pages 1827-1837

  Smith, Grace L ^a   Xu, Ying ^a   Buchholz, Thomas A ^a   Giordano, Sharon H ^a   Jiang, Jing ^a   Shih, Ya Chen Tina ^b   Smith, Benjamin D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; AGED; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT NECROSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MEDICARE; ORGAN PRESERVATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIB FRACTURE; SURVIVAL RATE;

EID: 84860456846     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.3481     Document Type: Article

References (37)

1. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74 (4):987-1001.
2. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg. 2009;209(2):269-277.
3. Smith GL, Xu Y, Buchholz TA, et al. Brachytherapy for accelerated partial-breast irradiation. J Clin Oncol. 2011;29(2):157-165.
4. Abbott AM, Habermann EB, Tuttle TM. Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States. Cancer. 2011;117(15):3305-3310.
5. Hattangadi JA, Taback N, Neville BA, Harris JR, Punglia RS. Accelerated partial breast irradiation using brachytherapy for breast cancer. J Natl Cancer Inst. 2012;104(1):29-41.
6. MammoSite: targeted radiation therapy. Hologic Inc website. www.mammosite.com/physicians. Accessed October 30, 2008.
7. Clarke M, Collins R, Darby S, et al Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087- 2106.
8. Darby S, McGale P, Correa C, et al Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death. Lancet. 2011;378(9804):1707-1716.
9. Buchholz TA. Partial breast irradiation - is it ready for prime time? Int J Radiat Oncol Biol Phys. 2003; 57(5):1214-1216. (Pubitemid 37443956)
10. Norris D, Julian TB. Update on the NSABP B-39/ RTOG 0413 Clinical Trial. Oncology Issues. Jan-Feb 2008:20-21.
11. Medicare Utilization & Enrollment. Research Data Assistance Center. http://www.resdac.umn.edu /Medicare. Updated August 11, 2011. Accessed March 2011.
12. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8) (suppl):IV-3-IV-18.
13. Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL. An algorithm for the use of Medicare claims data to identify womenwith incident breast cancer. Health Serv Res. 2004;39(6 pt 1):1733- 1749.
14. Gold HT, Do HT. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Health Serv Res. 2007;42(5):2056-2069. (Pubitemid 47397185)
15. Mandelblatt JS, Potosky AL. On the road to improving the quality of breast cancer care. Med Care. 2008;46(8):759-761.
16. Punglia RS, Saito AM, Neville BA, Earle CC, Weeks JC. Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer. BMJ. 2010;340:c845.
17. Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst. 2006;98(10):681-690. (Pubitemid 43821786)
18. Smith BD, Haffty BG, Buchholz TA, et al. Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst. 2006; 98(18):1302-1310. (Pubitemid 44538160)
19. Srokowski TP, Fang S, Duan Z, et al. Completion of adjuvant radiation therapy among women with breast cancer. Cancer. 2008;113(1):22-29. (Pubitemid 351976382)
20. Klabunde CN, Potosky AL, Legler JM,Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258- 1267.
21. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data. Med Care. 2002;40 (8)(suppl):IV-26-IV-35.
22. Area Resource File (ARF): 2009-2010. Department of Health and Human Services. http://arf.hrsa. gov. Accessed March 15, 2012.
23. Area Resource File (ARF). Area Resource File (ARF): 2007-2008. Department of Health and Human Services. http://arf.hrsa.gov. Accessed March 15, 2012.
24. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
25. Bender R. Calculating confidence intervals for the number needed to treat. Control Clin Trials. 2001; 22(2):102-110. (Pubitemid 32289446)
26. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference, Cary, NC: SAS Institute Inc. 2001:214-226.
27. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17(19):2265-2281.
28. Dupont WD, PlummerWD Jr. Power and sample size calculations. Control Clin Trials. 1990;11(2): 116-128.
29. Shaitelman SF, Vicini FA, Beitsch P, Haffty B, Keisch M, Lyden M. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation. Cancer. 2010; 116(20):4677-4685.
30. Polgár C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma. Int J Radiat Oncol Biol Phys. 2007;69(3):694-702. (Pubitemid 47418409)
31. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial). Lancet. 2010;376(9735):91-102.
32. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25): 1887-1892. (Pubitemid 30419054)
33. Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011;29(29):3885-3891.
34. Vicini F, Arthur D, Wazer D, et al. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;79(4):977-984.
35. Husain ZA, Mahmood U, Hanlon A, et al. Accelerated partial breast irradiation via brachytherapy. Brachytherapy. 2011;10(6):479-485.
36. Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I. Multicentricity of breast cancer. Br J Cancer. 1996;74(5):820-824.
37. Holland R, Veling SH,Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Cancer. 1985;56(5):979-990.